Naltrexone FDA Link Generic

Derivative of noroxymorphone that is the N-cyclopropylmethyl congener of NALOXONE. It is a narcotic antagonist that is effective orally, longer lasting and more potent than naloxone, and has been proposed for the treatment of heroin addiction. The FDA has approved naltrexone for the treatment of alcohol dependence.

Also Known As:

ReVia; Antaxone; Bristol-Myers Squibb Brand of Naltrexone Hydrochloride; Celupan; Du Pont Brand of Naltrexone Hydrochloride; EN-1639A; Lacer Brand of Naltrexone Hydrochloride; Lamepro Brand of Naltrexone Hydrochloride; Nalorex; Naltrexone Hydrochloride; Nemexin; Orphan Brand of Naltrexone Hydrochloride; Pharmazam Brand of Naltrexone Hydrochloride; Schering-Plough Brand of Naltrexone Hydrochloride; Trexan; United Drug Brand of Naltrexone Hydrochloride; Bristol Myers Squibb Brand of Naltrexone Hydrochloride; EN 1639A; EN1639A; Hydrochloride, Naltrexone; Schering Plough Brand of Naltrexone Hydrochloride; Morphinan-6-one, 17- (cyclopropylmethyl)- 4,5- epoxy- 3,14- dihydroxy- , (5alpha)-

Pharmalogical Action Categories:

Narcotic Antagonists

Heterocyclic Compounds: 60
- Alkaloids: 1065
  - Opiate Alkaloids: 10
    - Morphinans: 10
      - Naloxone: 4163
        Naltrexone: 1331
- Bridged-Ring Heterocyclic Compounds
  - Morphinans: 10
    - Naloxone: 4163
      - Naltrexone: 1331
- Heterocyclic Compounds with 4 or More Rings
  - Morphinans: 10
    - Naloxone: 4163
      - Naltrexone: 1331
Polycyclic Compounds: 56
- Aromatic Polycyclic Hydrocarbons: 831
  - Phenanthrenes: 8
    - Morphinans: 10
      - Naloxone: 4163
        Naltrexone: 1331

Create Custom RSS News Feed:
	Naltrexone (ReVia)

Alkermes Inc Product Research

Products